The DOI matches its Crossref record; 91 of the 91 references it cites were found in a registry or an index.
Target profiling of small molecules by chemical proteomics
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Quantitative Monitoring of Gene Expression Patterns with a Complementary DNA Microarray
Schena, M., Shalon, D., Davis, R. W., & Brown, P. O. (1995) · Science · doi:10.1126/science.270.5235.467 · Cited by 9,609
Zwischenmolekulare Energiewanderung und Fluoreszenz
Förster, T. (1948) · Annalen der Physik · doi:10.1002/andp.19484370105 · Cited by 8,285
Mass spectrometry-based proteomics
Aebersold, R., & Mann, M. (2003) · Nature · doi:10.1038/nature01511 · Cited by 6,955
Lamb, J., Crawford, E. D., Peck, D., Modell, J. W., Blat, I. C., Wrobel, M. J., Lerner, J., Brunet, J.-P., Subramanian, A., Ross, K. N., et al. (2006) · Science · doi:10.1126/science.1132939 · Cited by 5,257
Quantitative analysis of complex protein mixtures using isotope-coded affinity tags
Gygi, S. P., Rist, B., Gerber, S. A., Turecek, F., Gelb, M. H., & Aebersold, R. (1999) · Nature Biotechnology · doi:10.1038/13690 · Cited by 4,683
How many drug targets are there?
Overington, J. P., Al-Lazikani, B., & Hopkins, A. L. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2199 · Cited by 3,505
A generic protein purification method for protein complex characterization and proteome exploration
Rigaut, G., Shevchenko, A., Rutz, B., Wilm, M., Mann, M., & Séraphin, B. (1999) · Nature Biotechnology · doi:10.1038/13732 · Cited by 2,707
Targeting cancer with small molecule kinase inhibitors
Zhang, J., Yang, P. L., & Gray, N. S. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2559 · Cited by 2,576
The selectivity of protein kinase inhibitors: a further update
Bain, J., Plater, L., Elliott, M., Shpiro, N., Hastie, C. J., Mclauchlan, H., Klevernic, I., Arthur, J. S. C., Alessi, D. R., & Cohen, P. (2007) · Biochemical Journal · doi:10.1042/bj20070797 · Cited by 2,520
A quantitative analysis of kinase inhibitor selectivity
Karaman, M. W., Herrgard, S., Treiber, D. K., Gallant, P., Atteridge, C. E., Campbell, B. T., Chan, K. W., Ciceri, P., Davis, M. I., Edeen, P. T., et al. (2008) · Nature Biotechnology · doi:10.1038/nbt1358 · Cited by 2,466
Zhou, H.-X., Rivas, G., & Minton, A. P. (2008) · Annual Review of Biophysics · doi:10.1146/annurev.biophys.37.032807.125817 · Cited by 2,149
Proteomic analysis of post-translational modifications
Mann, M., & Jensen, O. N. (2003) · Nature Biotechnology · doi:10.1038/nbt0303-255 · Cited by 2,134
A small molecule–kinase interaction map for clinical kinase inhibitors
Fabian, M. A., Biggs, W. H., Treiber, D. K., Atteridge, C. E., Azimioara, M. D., Benedetti, M. G., Carter, T. A., Ciceri, P., Edeen, P. T., Floyd, M., et al. (2005) · Nature Biotechnology · doi:10.1038/nbt1068 · Cited by 1,892
Analytical Properties of the Nanoelectrospray Ion Source
Wilm, M., & Mann, M. (1996) · Analytical Chemistry · doi:10.1021/ac9509519 · Cited by 1,868
A Mammalian Histone Deacetylase Related to the Yeast Transcriptional Regulator Rpd3p
Taunton, J., Hassig, C. A., & Schreiber, S. L. (1996) · Science · doi:10.1126/science.272.5260.408 · Cited by 1,829
Quantitative mass spectrometry in proteomics: a critical review
Bantscheff, M., Schirle, M., Sweetman, G., Rick, J., & Kuster, B. (2007) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-007-1486-6 · Cited by 1,669
Mass spectrometry–based proteomics turns quantitative
Ong, S.-E., & Mann, M. (2005) · Nature Chemical Biology · doi:10.1038/nchembio736 · Cited by 1,572
A receptor for the immuno-suppressant FK506 is a cis–trans peptidyl-prolyl isomerase
Harding, M. W., Galat, A., Uehling, D. E., & Schreiber, S. L. (1989) · Nature · doi:10.1038/341758a0 · Cited by 1,396
In vivo drug discovery in the zebrafish
Zon, L. I., & Peterson, R. T. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1606 · Cited by 1,353
Selective enzyme purification by affinity chromatography.
Cuatrecasas, P., Wilchek, M., & Anfinsen, C. B. (1968) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.61.2.636 · Cited by 1,223
Buchdunger, E., Zimmermann, J., Mett, H., Meyer, T., Müller, M., Druker, B. J., & Lydon, N. (1996) · PubMed · Cited by 1,057
Quantitative chemical proteomics reveals mechanisms of action of clinical ABL kinase inhibitors
Bantscheff, M., Eberhard, D., Abraham, Y., Bastuck, S., Boesche, M., Hobson, S., Mathieson, T., Perrin, J., Raida, M., Rau, C., et al. (2007) · Nature Biotechnology · doi:10.1038/nbt1328 · Cited by 1,034
Accurate quantitation of protein expression and site-specific phosphorylation
Oda, Y., Huang, K., Cross, F. R., Cowburn, D., & Chait, B. T. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.12.6591 · Cited by 1,006
A functional genomics strategy that uses metabolome data to reveal the phenotype of silent mutations
Raamsdonk, L. M., Teusink, B., Broadhurst, D., Zhang, N., Hayes, A., Walsh, M. C., Berden, J. A., Brindle, K. M., Kell, D. B., Rowland, J. J., et al. (2001) · Nature Biotechnology · doi:10.1038/83496 · Cited by 1,005
The Chemical Genomic Portrait of Yeast: Uncovering a Phenotype for All Genes
Hillenmeyer, M. E., Fung, E., Wildenhain, J., Pierce, S. E., Hoon, S., Lee, W., Proctor, M., St.Onge, R. P., Tyers, M., Koller, D., et al. (2008) · Science · doi:10.1126/science.1150021 · Cited by 1,003
Feher, M., & Schmidt, J. M. (2003) · Journal of Chemical Information and Computer Sciences · doi:10.1021/ci0200467 · Cited by 927
Rix, U., Hantschel, O., Dürnberger, G., Remsing Rix, L. L., Planyavsky, M., Fernbach, N. V., Kaupe, I., Bennett, K. L., Valent, P., Colinge, J., et al. (2007) · Blood · doi:10.1182/blood-2007-07-102061 · Cited by 671
Self-citationSplicing factor SF3b as a target of the antitumor natural product pladienolide
Kotake, Y., Sagane, K., Owa, T., Mimori-Kiyosue, Y., Shimizu, H., Uesugi, M., Ishihama, Y., Iwata, M., & Mizui, Y. (2007) · Nature Chemical Biology · doi:10.1038/nchembio.2007.16 · Cited by 657
Spliceostatin A targets SF3b and inhibits both splicing and nuclear retention of pre-mRNA
Kaida, D., Motoyoshi, H., Tashiro, E., Nojima, T., Hagiwara, M., Ishigami, K., Watanabe, H., Kitahara, T., Yoshida, T., Nakajima, H., et al. (2007) · Nature Chemical Biology · doi:10.1038/nchembio.2007.18 · Cited by 650
Systematic discovery of multicomponent therapeutics
Borisy, A. A., Elliott, P. J., Hurst, N. W., Lee, M. S., Lehár, J., Price, E. R., Serbedzija, G., Zimmermann, G. R., Foley, M. A., Stockwell, B. R., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1337088100 · Cited by 620
Dynamic Proteomics of Individual Cancer Cells in Response to a Drug
Cohen, A. A., Geva-Zatorsky, N., Eden, E., Frenkel-Morgenstern, M., Issaeva, I., Sigal, A., Milo, R., Cohen-Saidon, C., Liron, Y., Kam, Z., et al. (2008) · Science · doi:10.1126/science.1160165 · Cited by 596
Daub, H., Olsen, J. V., Bairlein, M., Gnad, F., Oppermann, F. S., Körner, R., Greff, Z., Kéri, G., Stemmann, O., & Mann, M. (2008) · Molecular Cell · doi:10.1016/j.molcel.2008.07.007 · Cited by 594
Exploring biology with small organic molecules
Stockwell, B. R. (2004) · Nature · doi:10.1038/nature03196 · Cited by 470
Griffith, E. C., Su, Z., Turk, B. E., Chen, S., Chang, Y.-H., Wu, Z., Biemann, K., & Liu, J. O. (1997) · Chemistry & Biology · doi:10.1016/s1074-5521(97)90198-8 · Cited by 421
Deciphering Protein–Protein Interactions. Part I. Experimental Techniques and Databases
Shoemaker, B. A., & Panchenko, A. R. (2007) · PLoS Computational Biology · doi:10.1371/journal.pcbi.0030042 · Cited by 398
An efficient tandem affinity purification procedure for interaction proteomics in mammalian cells
Bürckstümmer, T., Bennett, K. L., Preradovic, A., Schütze, G., Hantschel, O., Superti-Furga, G., & Bauch, A. (2006) · Nature Methods · doi:10.1038/nmeth968 · Cited by 391
Self-citationRoscovitine Targets, Protein Kinases and Pyridoxal Kinase
Bach, S., Knockaert, M., Reinhardt, J., Lozach, O., Schmitt, S., Baratte, B., Koken, M., Coburn, S. P., Tang, L., Jiang, T., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m500806200 · Cited by 356
An efficient proteomics method to identify the cellular targets of protein kinase inhibitors
Godl, K., Wissing, J., Kurtenbach, A., Habenberger, P., Blencke, S., Gutbrod, H., Salassidis, K., Stein-Gerlach, M., Missio, A., Cotten, M., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2535024100 · Cited by 336
Flying under the radar: the new wave of BCR–ABL inhibitors
Quintás-Cardama, A., Kantarjian, H., & Cortes, J. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2324 · Cited by 305
Identifying the proteins to which small-molecule probes and drugs bind in cells
Ong, S.-E., Schenone, M., Margolin, A. A., Li, X., Do, K., Doud, M. K., Mani, D. R., Kuai, L., Wang, X., Wood, J. L., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0900191106 · Cited by 304
The Btk tyrosine kinase is a major target of the Bcr-Abl inhibitor dasatinib
Hantschel, O., Rix, U., Schmidt, U., Bürckstümmer, T., Kneidinger, M., Schütze, G., Colinge, J., Bennett, K. L., Ellmeier, W., Valent, P., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0702654104 · Cited by 284
Self-citationGlobal target profile of the kinase inhibitor bosutinib in primary chronic myeloid leukemia cells
Remsing Rix, L. L., Rix, U., Colinge, J., Hantschel, O., Bennett, K. L., Stranzl, T., Müller, A., Baumgartner, C., Valent, P., Augustin, M., et al. (2009) · Leukemia · doi:10.1038/leu.2008.334 · Cited by 284
Self-citationActivity-based protein profiling for the functional annotation of enzymes
Barglow, K. T., & Cravatt, B. F. (2007) · Nature Methods · doi:10.1038/nmeth1092 · Cited by 281
Booth, B., & Zemmel, R. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1384 · Cited by 278
An integrated workflow for charting the human interaction proteome: insights into the PP2A system
Glatter, T., Wepf, A., Aebersold, R., & Gstaiger, M. (2009) · Molecular Systems Biology · doi:10.1038/msb.2008.75 · Cited by 259
Parent Ion Scans of Unseparated Peptide Mixtures
Wilm, M., Neubauer, G., & Mann, M. (1996) · Analytical Chemistry · doi:10.1021/ac950875+ · Cited by 250
High-performance affinity beads for identifying drug receptors
Shimizu, N., Sugimoto, K., Tang, J., Nishi, T., Sato, I., Hiramoto, M., Aizawa, S., Hatakeyama, M., Ohba, R., Hatori, H., et al. (2000) · Nature Biotechnology · doi:10.1038/78496 · Cited by 250
Inhibition of Eukaryotic Translation Initiation by the Marine Natural Product Pateamine A
Low, W.-K., Dang, Y., Schneider-Poetsch, T., Shi, Z., Choi, N. S., Merrick, W. C., Romo, D., & Liu, J. O. (2005) · Molecular Cell · doi:10.1016/j.molcel.2005.10.008 · Cited by 250
Tagging and detection strategies for activity-based proteomics
Sadaghiani, A. M., Verhelst, S. H., & Bogyo, M. (2007) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2006.11.030 · Cited by 245
Bachovchin, D. A., Brown, S. J., Rosen, H., & Cravatt, B. F. (2009) · Nature Biotechnology · doi:10.1038/nbt.1531 · Cited by 245
Selectivity and therapeutic inhibition of kinases: to be or not to be?
Ghoreschi, K., Laurence, A., & O'Shea, J. J. (2009) · Nature Immunology · doi:10.1038/ni.1701 · Cited by 241
Brehmer, D., Greff, Z., Godl, K., Blencke, S., Kurtenbach, A., Weber, M., Müller, S., Klebl, B., Cotten, M., Kéri, G., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.379.65.2 · Cited by 241
Schirle, M., Heurtier, M.-A., & Kuster, B. (2003) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m300087-mcp200 · Cited by 229
Bordeleau, M.-E., Matthews, J., Wojnar, J. M., Lindqvist, L., Novac, O., Jankowsky, E., Sonenberg, N., Northcote, P., Teesdale-Spittle, P., & Pelletier, J. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0504249102 · Cited by 228
AXL Is a Potential Target for Therapeutic Intervention in Breast Cancer Progression
Zhang, Y.-X., Knyazev, P. G., Cheburkin, Y. V., Sharma, K., Knyazev, Y. P., Őrfi, L., Szabadkai, I., Daub, H., Kéri, G., & Ullrich, A. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-2661 · Cited by 210
A Tandem Orthogonal Proteolysis Strategy for High-Content Chemical Proteomics
Speers, A. E., & Cravatt, B. F. (2005) · Journal of the American Chemical Society · doi:10.1021/ja0532842 · Cited by 204
The Art and Practice of Systems Biology in Medicine: Mapping Patterns of Relationships
van der Greef, J., Martin, S., Juhasz, P., Adourian, A., Plasterer, T., Verheij, E. R., & McBurney, R. N. (2007) · Journal of Proteome Research · doi:10.1021/pr0606530 · Cited by 201
Quantitative Chemical Proteomics for Identifying Candidate Drug Targets
Oda, Y., Owa, T., Sato, T., Boucher, B., Daniels, S., Yamanaka, H., Shinohara, Y., Yokoi, A., Kuromitsu, J., & Nagasu, T. (2003) · Analytical Chemistry · doi:10.1021/ac026196y · Cited by 190
Charting the molecular network of the drug target Bcr-Abl
Brehme, M., Hantschel, O., Colinge, J., Kaupe, I., Planyavsky, M., Köcher, T., Mechtler, K., Bennett, K. L., & Superti-Furga, G. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0900653106 · Cited by 170
Self-citationA Mild Chemically Cleavable Linker System for Functional Proteomic Applications
Verhelst, S. H. L., Fonović, M., & Bogyo, M. (2007) · Angewandte Chemie International Edition · doi:10.1002/anie.200603811 · Cited by 163
RNA-Mediated Sequestration of the RNA Helicase eIF4A by Pateamine A Inhibits Translation Initiation
Bordeleau, M.-E., Cencic, R., Lindqvist, L., Oberer, M., Northcote, P., Wagner, G., & Pelletier, J. (2006) · Chemistry & Biology · doi:10.1016/j.chembiol.2006.10.005 · Cited by 161
Doucet, A., Butler, G. S., Rodriáguez, D., Prudova, A., & Overall, C. M. (2008) · Molecular & Cellular Proteomics · doi:10.1074/mcp.r800012-mcp200 · Cited by 150
Proteome analysis using selective incorporation of isotopically labeled amino acids
Veenstra, T. D., Martinović, S., Anderson, G., Paša‐Tolić, L., & Smith, R. D. (2000) · Journal of the American Society for Mass Spectrometry · doi:10.1016/s1044-0305(99)00120-8 · Cited by 142
GTP-dependent binding of the antiproliferative agent didemnin to elongation factor 1 alpha.
Crews, C. M., Collins, J. L., Lane, W. S., Snapper, M. L., & Schreiber, S. L. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)40692-2 · Cited by 140
Synthesis and Target Identification of Hymenialdisine Analogs
Wan, Y., Hur, W., Cho, C. Y., Liu, Y., Adrian, F. J., Lozach, O., Bach, S., Mayer, T., Fabbro, D., Meijer, L., et al. (2004) · Chemistry & Biology · doi:10.1016/j.chembiol.2004.01.015 · Cited by 140
Small-molecule synergist of the Wnt/β-catenin signaling pathway
Zhang, Q., Major, M. B., Takanashi, S., Camp, N. D., Nishiya, N., Peters, E. C., Ginsberg, M. H., Jian, X., Randazzo, P. A., Schultz, P. G., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0702136104 · Cited by 139
A Three-Hybrid Approach to Scanning the Proteome for Targets of Small Molecule Kinase Inhibitors
Becker, F., Murthi, K. K., Smith, C. C., Come, J. H., COSTAROLDAN, N., Kaufmann, C. M., Hanke, U., Degenhart, C., Baumann, S. W., Wallner, W., et al. (2004) · Chemistry & Biology · doi:10.1016/j.chembiol.2004.02.001 · Cited by 139
Wang, G., Shang, L., Burgett, A. W. G., Harran, P. G., & Wang, X. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0610832104 · Cited by 133
A Mild Chemically Cleavable Linker System for Functional Proteomic Applications
Verhelst, S. H. L., Fonovič, M., & Bogyo, M. S. (2007) · Angewandte Chemie · doi:10.1002/ange.200603811 · Cited by 133
Scholten, A., Poh, M. K., van Veen, T. A. B., van Breukelen, B., Vos, M. A., & Heck, A. J. R. (2006) · Journal of Proteome Research · doi:10.1021/pr0600529 · Cited by 116
Brehmer, D., Godl, K., Zech, B., Wissing, J. B., & Daub, H. (2004) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m300139-mcp200 · Cited by 106
The structure of the leukemia drug imatinib bound to human quinone reductase 2 (NQO2)
Winger, J. A., Hantschel, O. D., Superti‐Furga, G., & Kuriyan, J. (2009) · BMC Structural Biology · doi:10.1186/1472-6807-9-7 · Cited by 105
Self-citationGodl, K., Gruß, O. J., Eickhoff, J., Wissing, J. B., Blencke, S., Weber, M., Degen, H., Brehmer, D., Őrfi, L., Horváth, Z., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0574 · Cited by 105
Proteomics Evaluation of Chemically Cleavable Activity-based Probes
Fonovič, M., Verhelst, S. H. L., Sorum, M. T., & Bogyo, M. S. (2007) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m700124-mcp200 · Cited by 100
Unfinished business: target-based drug discovery
Brown, D. (2007) · Drug Discovery Today · doi:10.1016/j.drudis.2007.10.017 · Cited by 98
The identification of myriocin-binding proteins
Chen, J. M., Lane, W. S., & Schreiber, S. L. (1999) · Chemistry & Biology · doi:10.1016/s1074-5521(99)80038-6 · Cited by 95
An Unbiased Evaluation of CK2 Inhibitors by Chemoproteomics
Duncan, J. S., Gyenis, L., Lenehan, J. G., Bretner, M., Graves, L. M., Haystead, T., & Litchfield, D. W. (2008) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m700559-mcp200 · Cited by 95
Quality, not Quantity: The Role of Natural Products and Chemical Proteomics in Modern Drug Discovery
Piggott, A. M. (2004) · Combinatorial Chemistry & High Throughput Screening · doi:10.2174/1386207043328409 · Cited by 92
Wissing, J. B., Godl, K., Brehmer, D., Blencke, S., Weber, M., Habenberger, P., Stein-Gerlach, M., Missio, A., Cotten, M. L., Müller, S., et al. (2004) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m400124-mcp200 · Cited by 86
Metabolomics and biochemical profiling in drug discovery and development.
Watkins, S. M., & German, J. B. (2002) · PubMed · Cited by 84
p42/p44 MAPKs are intracellular targets of the CDK inhibitor purvalanol
Knockaert, M., Lenormand, P., Gray, N. S., Schultz, P. G., Pouysségur, J., & Meijer, L. (2002) · Oncogene · doi:10.1038/sj.onc.1205908 · Cited by 64
(−)‐FR182877 Is a Potent and Selective Inhibitor of Carboxylesterase‐1
Adam, G. C., Vanderwal, C. D., Sorensen, E. J., & Cravatt, B. F. (2003) · Angewandte Chemie International Edition · doi:10.1002/anie.200352576 · Cited by 63
Scholten, A., van Veen, T. A. B., Vos, M. A., & Heck, A. J. R. (2007) · Journal of Proteome Research · doi:10.1021/pr060601a · Cited by 56
Low, W., Dang, Y., Bhat, S., Romo, D., & Liu, J. O. (2007) · Chemistry & Biology · doi:10.1016/j.chembiol.2007.05.012 · Cited by 54
Shiyama, T., Furuya, M., Yamazaki, A., Terada, T., & Tanaka, A. (2004) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2004.03.052 · Cited by 53
Chemical and Pathway Proteomics
Kruse, U., Bantscheff, M., Drewes, G., & Hopf, C. (2008) · Molecular & Cellular Proteomics · doi:10.1074/mcp.r800006-mcp200 · Cited by 49
Chemical tools for activity-based proteomics
Hagenstein, M. C., & Sewald, N. (2006) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2005.12.005 · Cited by 46
Chemical proteomics for drug discovery based on compound-immobilized affinity chromatography
Katayama, H., & Oda, Y. (2007) · Journal of Chromatography B · doi:10.1016/j.jchromb.2006.12.047 · Cited by 46
Aye, T. T., Mohammed, S., van den Toorn, H., van Veen, T. A. B., van der Heyden, M. A. G., Scholten, A., & Heck, A. J. R. (2009) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m800226-mcp200 · Cited by 45
Fauq, A. H., Kache, R., Khan, M. A., et al. (2005) · Bioconjugate Chemistry · doi:10.1021/bc0503059 · Cited by 42
Mizuarai, S., Irie, H., Schmatz, D. M., & Kotani, H. (2008) · Current Molecular Medicine · doi:10.2174/156652408786733676 · Cited by 18
Cited by
Mass-spectrometric exploration of proteome structure and function
Aebersold, R., & Mann, M. (2016) · Nature · doi:10.1038/nature19949 · Cited by 2,334
Natural Products for Drug Discovery in the 21st Century: Innovations for Novel Drug Discovery
Thomford, N. E., Senthebane, D. A., Rowe, A., Munro, D., Seele, P., Maroyi, A., & Dzobo, K. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19061578 · Cited by 1,241
Target identification and mechanism of action in chemical biology and drug discovery
Schenone, M., Dančík, V., Wagner, B. K., & Clemons, P. A. (2013) · Nature Chemical Biology · doi:10.1038/nchembio.1199 · Cited by 1,096
Sharma, K., D’Souza, R. C. J., Tyanova, S., Schaab, C., Wiśniewski, J. R., Cox, J., & Mann, M. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.07.036 · Cited by 969
Target Identification for Small Bioactive Molecules: Finding the Needle in the Haystack
Ziegler, S., Pries, V., Hedberg, C., & Waldmann, H. (2013) · Angewandte Chemie International Edition · doi:10.1002/anie.201208749 · Cited by 466
Metadata
- Authors
- Rix, U., & Superti-Furga, G.
- Venue
- Nature Chemical Biology
- Published
- 2008-09-18
- Volume
- 5
- Issue
- 9
- Pages
- 616-624
- ISSN
- 1552-4450 (ISSN-L)
- 1552-4469
- OpenAlex
- W1968327387
- Cited by
- 575
- References
- 91
- FWCI
- 13.45
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.